Followers | 66 |
Posts | 4898 |
Boards Moderated | 0 |
Alias Born | 06/12/2014 |
Wednesday, October 16, 2019 11:44:29 PM
Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements
GlobeNewswireOctober 17, 2019, 2:08 AM UTC
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE:IPOT) formerly Atlas Blockchain Group Inc. (CSE:AKE) (A49.F) (ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company will commence trading at market open on October 17, 2019.
Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. For more information visit: www.isracann.com.
https://finance.yahoo.com/news/isracann-biosciences-announces-listing-cse-020849216.html
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM